ClinicalTrials.gg
Drug

Lactulose clinical trials

studies test it
54
open now
5
in phase 3
8
first study started
1994

How each study uses Lactulose is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Lactulose studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 Mar 1976 · CEPHULAC · NDA 017657 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Lactulose
37
Kristalose
4
Lactulose oral solution
2

Brand

Enulose
1
Generlac
1
Cholac
1
Constulose
1
Laxilose
1
Portalac
1
Constilac
1
Duphalac®
1

In one entry with another drug

Given together, or one or the other

Rifaximin plus lactulose
2

Studies by the year they started

54 studies that test it; most in 2008 (5)

Studies that test Lactulose, by start year
YearStudies
19941
20002
20021
20031
20041
20051
20062
20071
20085
20093
20103
20112
20135
20144
20151
20161
20171
20201
20213
20223
20233
20244
20252
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
2
Phase 2
8
Phase 3
8
Phase 4
17
No phase
21

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 46

Institute of Liver and Biliary Sciences, India (4) · University of Michigan (2) · Avva Rus, JSC (2) · Solvay Pharmaceuticals (2) · Bnai Zion Medical Center (2) · Norgine (2) · Tongji Hospital (2) · Govind Ballabh Pant Hospital (2)

Often tested with

Tested in the same studies.

Rifaximin (11) · Polyethylene Glycols (5) · Polyethylene glycol 3350 (2) · Ornithylaspartate (2) · Probiotic (1) · Natamycin (1) · Prucalopride (1) · Bromocriptine (1)

Studies

Open first, then newest update. How each study uses Lactulose is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 54

See all 54 studies that test Lactulose →

Given beside what is tested · 15 — Lactulose is usual care or a partner of the new treatment
As the comparator · 16 — what is tested is compared with Lactulose

Codes

What other systems call Lactulose · ClinicalTrials.gg INT007722

  • MeSH (NLM) D007792LactuloseOne source ClinicalTrials.gov
  • UNII (FDA) 9U7D5QH5AELACTULOSEOne source FDA
  • RxNorm 6218One source FDA
  • NCI Thesaurus C29148LactuloseOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.